Articles

Articles 92 records found  previous11 - 20nextend  jump to record: Search took 0.01 seconds. 
11.
24 p, 1.3 MB Prevalence of Intoxicating Substance Use Before or During Sex Among Young Adults : A Systematic Review and Meta-Analysis / Gómez-Núñez, María Isabel (International University of La Rioja, UNIR. Department of Research Methods and Diagnostics in Education) ; Molla Esparza, Cristian (University of Valencia, UVEG. Department of Research Methods and Diagnostics in Education) ; Gandia Carbonell, Natalia (Universitat Autònoma de Barcelona. Departament de Psicobiologia i de Metodologia de Ciències de la Salut) ; Badenes Ribera, Laura (University of Valencia, UVEG. Department of Methodology of the Behavioural Sciences)
Drug use before or during sex is a high-risk sexual behavior associated with adverse health risks and outcomes, such as increasing the likelihood of overdoses and of acquiring sexually-transmitted diseases. [...]
2023 - 10.1007/s10508-023-02572-z
Archives of Sexual Behavior, Vol. 52 (march 2023) , p. 2503-2526  
12.
32 p, 3.8 MB Platinum-Based Nanoformulations for Glioblastoma Treatment : The Resurgence of Platinum Drugs? / Alfonso-Triguero, Paula (Institut Català de Nanociència i Nanotecnologia) ; Lorenzo Rivera, Julia (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Candiota Silveira, Ana Paula (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Arús i Caraltó, Carles (Institut Català de Nanociència i Nanotecnologia) ; Ruiz-Molina, Daniel (Institut Català de Nanociència i Nanotecnologia) ; Novio Vázquez, Fernando (Universitat Autònoma de Barcelona. Departament de Química)
Current therapies for treating Glioblastoma (GB), and brain tumours in general, are inefficient and represent numerous challenges. In addition to surgical resection, chemotherapy and radiotherapy are presently used as standards of care. [...]
2023 - 10.3390/nano13101619
Nanomaterials, Vol. 13, Issue 10 (May 2023) , art. 1619  
13.
7 p, 824.9 KB Utilisation of drugs for the treatment of psychiatric diseases in the pediatric population : focus on off-label use / Pesiou, Stella (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Barcelo, Rafel (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Fradera, Marc (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Torres, Ferran (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Pontes García, Caridad (Institut d'Investigació Biomèdica de Bellvitge)
Psychotropics are increasingly used in pediatrics, often as off-label medicines. The guarantees of safety and efficacy are not always granted in clinical practice compared to adult authorised indications. [...]
2023 - 10.3389/fphar.2023.1157135
Frontiers in Pharmacology, Vol. 14 (june 2023)  
14.
15 p, 5.4 MB Neural substrates of cognitive impairment in a NMDAR hypofunction mouse model of schizophrenia and partial rescue by risperidone / Delgado-Sallent, Cristina (Institut Hospital del Mar d'Investigacions Mèdiques) ; Gener, Thomas (Institut Català de Nanociència i Nanotecnologia) ; Nebot, Pau (Institut Hospital del Mar d'Investigacions Mèdiques) ; López-Cabezón, Cristina (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Puig, Maria Victoria (Institut Català de Nanociència i Nanotecnologia)
N-methyl D-aspartate receptor (NMDAR) hypofunction is a pathophysiological mechanism relevant for schizophrenia. Acute administration of the NMDAR antagonist phencyclidine (PCP) induces psychosis in patients and animals while subchronic PCP (sPCP) produces cognitive dysfunction for weeks. [...]
2023 - 10.3389/fncel.2023.1152248
Frontiers in cellular neuroscience, Vol. 17 (march 2023)  
15.
24 p, 184.0 KB Medicamentos órfãos em Portugal no contexto internacional (séculos XX-XXI) / Pita, João Rui (Universidade de Coimbra, Faculdade de Farmácia) ; Pereira, Ana Leonor (Universidade de Coimbra. Faculdade de Letras)
A consciência científica, clínica e pública da existência das doenças raras tem aumentado nos últimos anos. Os medicamentos denominados de "medicamentos órfãos" são aqueles que são apropriados para o tratamento de doenças raras. [...]
Scientific, clinical, and public awareness of the existence of rare diseases has increased over recent years. "Orphan drugs" are those that are suitable for the treatment of rare diseases. Rare diseases have a low demographic incidence in comparison to other diseases. [...]

2022 - 10.30827/dynamis.v42i2.27717
Dynamis : Acta Hispanica ad Medicinae Scientiarumque. Historiam Illustrandam, Vol. 42 Núm. 2 (2022) , p. 449-471 (Dossier)  
16.
17 p, 300.8 KB Expert opinion on the use of cladribine tablets in clinical practice / Sørensen, Per Soelberg (University of Copenhagen) ; Centonze, Diego (Unit of Neurology and Neurorehabilitation) ; Giovannoni, Gavin (Queen Mary University of London) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Selchen, Daniel (St. Michael's Hospital, Toronto) ; Vermersch, Patrick (Univ. Lille) ; Wiendl, Heinz (University of Münster) ; Yamout, Bassem (American University of Beirut) ; Salloukh, Hashem (Ares Trading S.A. Merck Serono S.A) ; Rieckmann, Peter (University of Erlangen) ; Universitat Autònoma de Barcelona. Departament de Medicina
Background: Gaps in current product labels and a lack of detailed clinical guidelines leaves clinicians' questions on the practical management of patients receiving cladribine tablets for the treatment of relapsing multiple sclerosis (MS) unanswered. [...]
2020 - 10.1177/1756286420935019
Therapeutic Advances in Neurological Disorders, Vol. 13 (2020)  
17.
15 p, 1.4 MB Critical role of interleukin (IL)-17 in inflammatory and immune disorders : An updated review of the evidence focusing in controversies / Ruiz de Morales, José María G. (Universidad de León) ; Puig, Lluís (Universitat Autònoma de Barcelona. Departament de Medicina) ; Daudén, Esteban (Hospital Universitario de la Princesa (Madrid)) ; Cañete, Juan D. (Hospital Clínic i Provincial de Barcelona) ; Pablos, José Luis (Hospital Universitario 12 de Octubre (Madrid)) ; Martín, Antonio Oliveira (Hospital Universitario La Paz (Madrid)) ; Juanatey, Carlos González (Hospital Universitario Lucus Augusti (Lugo)) ; Adan Civera, Alfredo (Hospital Clínic i Provincial de Barcelona) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Borruel, Natalia (Hospital Universitari Vall d'Hebron) ; Ortí, Guillermo (Vall d'Hebron Institut d'Oncologia) ; Holgado-Martín, Esther (Ruber Internacional) ; Garcia-Vidal, Carolina (Hospital Clínic i Provincial de Barcelona) ; Vizcaya-Morales, Cynthia (Novartis Pharma) ; Martín-Vázquez, Víctor (Novartis Farmacéutica) ; González-Gay, Miguel Ángel (Universidad de Cantabria)
Interleukin 17 (IL-17) is a proinflammatory cytokine that has been the focus of intensive research because of its crucial role in the pathogenesis of different diseases across many medical specialties. [...]
2020 - 10.1016/j.autrev.2019.102429
Autoimmunity Reviews, Vol. 19 Núm. 1 (january 2020) , p. 102429  
18.
21 p, 1.1 MB Novel Antithrombotic Agents in Ischemic Cardiovascular Disease : Progress in the Search for the Optimal Treatment / Barriuso, I. (Universitat Autònoma de Barcelona. Departament de Medicina) ; Worner, F. (Hospital Universitario Arnau de Vilanova. Institut de Recerca Biomèdica de Lleida) ; Vilahur, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Ischemic cardiovascular diseases have a high incidence and high mortality worldwide. Therapeutic advances in the last decades have reduced cardiovascular mortality, with antithrombotic therapy being the cornerstone of medical treatment. [...]
2022 - 10.3390/jcdd9110397
Journal of Cardiovascular Development and Disease, Vol. 9 Núm. 11 (november 2022) , p. 397  
19.
8 p, 429.8 KB Pharmacological cardioversion after pre-treatment with antiarrythmic drugs prior to electrical cardioversion in persistent atrial fibrillation : Impact on maintenance of sinus rhythm / El Amrani, Amine (Hospital Universitari Joan XXIII de Tarragona. Institut d'Investigació Sanitària Pere Virgili) ; Viñolas, Xavier (Institut d'Investigació Biomèdica Sant Pau) ; Arias, Miguel Ángel (Hospital Virgen de la Salud (Toledo)) ; Bazán, Víctor (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Valdovinos, Pilar (Hospital Universitari Joan XXIII de Tarragona. Institut d'Investigació Sanitària Pere Virgili) ; Alegret i Colomé, Josep Maria (Hospital Universitari Joan XXIII de Tarragona. Institut d'Investigació Sanitària Pere Virgili)
Background: Antiarrhythmic drugs (AADs) are frequently initiated in patients with persistent atrial fibrillation (AF) prior to electrical cardioversion (ECV), achieving pharmacological cardioversion (PCV) in some cases. [...]
2021 - 10.3390/jcm10051029
Journal of clinical medicine, Vol. 10 Núm. 5 (january 2021) , p. 1-8  
20.
7 p, 239.1 KB Association between chronic pain medications and the severity and mortality of COVID-19 : Study protocol for a case-population study / Serrano Afonso, Ancor (Institut d'Investigació Biomèdica de Bellvitge) ; Pérez Hernández, Concepción (Hospital Universitario de la Princesa (Madrid)) ; Ochoa Mazarro, Dolores (Hospital Universitario de la Princesa (Madrid)) ; Román Martínez, Manuel (Hospital Universitario de la Princesa (Madrid)) ; Failde Martínez, Inmaculada (Universidad de Cádiz) ; Montes Pérez, Antonio (Institut Hospital del Mar d'Investigacions Mèdiques) ; López Pais, P. (Complejo Hospitalario Universitario de Santiago de Compostela) ; Cánovas Martínez, Luz Noguero (Complejo Hospitalario Universitario de Ourense) ; Revuelta Rizo, Miren (Institut d'Investigació Biomèdica Sant Pau) ; Padilla-del-Rey, María-Luz (Complejo Hospitalario Universitario de Cartagena) ; Peiró Perió, Ana (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Aberasturi Fueyo, Teresa (Hospital Comarcal Alt Penedes) ; Margarit-Ferri, César (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Rojo Rodríguez, Elena (Hospital Universitario de la Princesa (Madrid)) ; Mendiola de La Osa, Agustín (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Muñoz Martinez, Manuel José (Hospital Universitario de la Princesa (Madrid)) ; Domínguez Bronchal, María Jesús (Complejo Hospitalario Universitario de Toledo) ; Herrero Trujillano, Manuel (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Cid Calzada, José (Complejo Hospitalario Universitario de Toledo) ; Fabregat-Cid, Gustavo (Hospital General Universitario de Valencia) ; Hernández-Cádiz, María José (Hospital General Universitario de Valencia) ; Mareque Ortega, Manuel (Complejo Hospitalario Universitario de Toledo) ; Gómez-Caro Álvarez Palencia, Leticia (Complejo Hospitalario Universitario de Toledo) ; Mayoral Rojals, Víctor (Institut d'Investigació Biomèdica de Bellvitge)
In patients with coronavirus disease 2019 (COVID-19) infection, common drugs may exacerbate symptoms and negatively impact outcomes. However, the role of chronic medications on COVID-19 effects remains poorly understood. [...]
2021 - 10.1097/MD.0000000000026725
Medicine, Vol. 100 Núm. 30 (July 2021) , p. E26725  

Articles : 92 records found   previous11 - 20nextend  jump to record:
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.